NAMPT and breast cancer: Our proposed molecular signature that is composed of 39 NAMPT-mediated genes is a promising prognostic marker, because N39 was solely developed based on the discovery cohort and its prognostic power was validated in two independent validation cohorts for lung and breast cancer, respectively.